{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:52:30Z","timestamp":1761058350048},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T00:00:00Z","timestamp":1130284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00403-005-0607-3","type":"journal-article","created":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T10:10:47Z","timestamp":1130235047000},"page":"266-273","source":"Crossref","is-referenced-by-count":20,"title":["Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis"],"prefix":"10.1007","volume":"297","author":[{"given":"Philippe","family":"Paquet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Damas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Pirson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rald","family":"Pi\u00e9rard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,10,26]]},"reference":[{"key":"607_CR1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","volume":"48","author":"J Arevalo","year":"2000","unstructured":"Arevalo J, Lorente JA, Gonzalez-Herrada C, Jimenez-Reyes J (2000) Treatment of toxic epidermal necrolysis with cyclosporin A. J Trauma Inj Inf Crit Care 48:473\u2013478","journal-title":"J Trauma Inj Inf Crit Care"},{"key":"607_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.139.1.33","volume":"139","author":"N Bachot","year":"2003","unstructured":"Bachot N, Revuz J, Roujeau JC (2003) Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol 139:33\u201336","journal-title":"Arch Dermatol"},{"key":"607_CR3","first-page":"149","volume":"45","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 45:149\u2013153","journal-title":"J Invest Dermatol"},{"key":"607_CR4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol 129:92\u201396","journal-title":"Arch Dermatol"},{"key":"607_CR5","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)11369-1","volume":"351","author":"DS Becker","year":"1998","unstructured":"Becker DS (1998) Toxic epidermal necrolysis. Lancet 351:1417\u20131420","journal-title":"Lancet"},{"key":"607_CR6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00007611-199610000-00015","volume":"89","author":"NG Frangogiannis","year":"1996","unstructured":"Frangogiannis NG, Boridy F, Mazhar M, Mathews R, Gangopadhyay S, Cate T (1996) Cyclophosphamide in the treatment of toxic epidermal necrolysis. South Med J 89:1001\u20131003","journal-title":"South Med J"},{"key":"607_CR7","first-page":"3823","volume":"57","author":"S Fulda","year":"1997","unstructured":"Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM (1997) The CD95 (APO-1Fas) system mediates drug-induces apoptosis in neuroblastoma cells. Cancer Res 57:3823\u20133829","journal-title":"Cancer Res"},{"key":"607_CR8","first-page":"340","volume":"180","author":"D Herndon","year":"1995","unstructured":"Herndon D (1995) Toxic epidermal necrolysis: a systemic and dermatologic disorder best treated with standard treatment protocols in burns intensive care units without the prolonged use of corticosteroids. J Am Coll Surg 180:340\u2013342","journal-title":"J Am Coll Surg"},{"key":"607_CR9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2230.1997.tb01044.x","volume":"22","author":"P Jarrett","year":"1997","unstructured":"Jarrett P, Rademaker M, Havill J, Pullon H (1997) Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony simulating factor. Clin Exp Dermatol 22:146\u2013147","journal-title":"Clin Exp Dermatol"},{"key":"607_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2133.2000.03265.x","volume":"142","author":"S Magina","year":"2000","unstructured":"Magina S, Lisboa C, Goncalves E, Conceicao P, Leal U, Mesquita-Guimaraes J (2000) A case of toxic epidermal necrolysis treated with intravenous immunoglobulin. Br J Dermatol 142:177\u2013178","journal-title":"Br J Dermatol"},{"key":"607_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1027\/0838-1925.14.4.143","volume":"14","author":"M Mockenhaupt","year":"2002","unstructured":"Mockenhaupt M, Norgauer J (2002) Cutaneous adverse drug reactions: Stevens-Johnson syndrome and toxic epidermal necrolysis. Allergy Clin Immunol Int 14:143\u2013150","journal-title":"Allergy Clin Immunol Int"},{"key":"607_CR12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2230.1997.tb01086.x","volume":"22","author":"SR Murdoch","year":"1997","unstructured":"Murdoch SR, Fenton DA (1997) Toxic epidermal necrolysis and cyclosporin. Clin Exp Dermatol 22:250\u2013256","journal-title":"Clin Exp Dermatol"},{"key":"607_CR13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000247481","volume":"105","author":"P Paquet","year":"1992","unstructured":"Paquet P, Arrese Estrada J, Pi\u00e9rard GE (1992) Oral cyclosporin and alopecia aerata. Dermatology 105:314\u2013315","journal-title":"Dermatology"},{"key":"607_CR14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0305-4179(01)00005-5","volume":"27","author":"P Paquet","year":"2001","unstructured":"Paquet P, Jacob E, Damas P, Pi\u00e9rard GE (2001) Treatment of drug-induced toxic epidermal necrolysis (Lyell\u2019s syndrome) with intravenous human immunoglobulins. Burns 27:652\u2013655","journal-title":"Burns"},{"key":"607_CR15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000018112","volume":"198","author":"P Paquet","year":"1999","unstructured":"Paquet P, Pi\u00e9rard GE (1999) Would cyclosporin A be beneficial to mitigate drug-induced toxic epidermal necrolysis? Dermatology 198:198\u2013202","journal-title":"Dermatology"},{"key":"607_CR16","first-page":"695","volume":"10","author":"P Paquet","year":"2002","unstructured":"Paquet P, Pi\u00e9rard GE (2002) Differential patomechanisms of epidermal necrolytic blistering diseases. Int J Mol Med 10:695\u2013699","journal-title":"Int J Mol Med"},{"key":"607_CR17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2834.2002.00309.x","volume":"10","author":"P Paquet","year":"2002","unstructured":"Paquet P, Pi\u00e9rard GE (2002) Keratinocyte injury in drug-induced toxic epidermal necrolysis: simultaneous but distinct topographic expression of CD95R and calprotectin. Int J Mol Med 10:145\u2013147","journal-title":"Int J Mol Med"},{"key":"607_CR18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000083947","volume":"136","author":"P Paquet","year":"2005","unstructured":"Paquet P, Pi\u00e9rard GE, Quatresooz P (2005) Novel treatments for drug-induced toxic epidermal necrolysis (Lyell\u2019s syndrome). Int Arch Allergy Immunol 136:205\u2013216","journal-title":"Int Arch Allergy Immunol"},{"key":"607_CR19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1440-0960.1999.00347.x","volume":"40","author":"TG Phan","year":"1999","unstructured":"Phan TG, Wang R, Crotty T, Adelstein S (1999) Toxic epidermal necrolysis treated with intravenous gammaglobulin. Australas J Dermatol 40:153\u2013157","journal-title":"Australas J Dermatol"},{"key":"607_CR20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.139.1.26","volume":"139","author":"C Prins","year":"2003","unstructured":"Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I et al (2003) Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins. Arch Dermatol 139:26\u201332","journal-title":"Arch Dermatol"},{"key":"607_CR21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-4362.1989.tb02502.x","volume":"28","author":"L Renfro","year":"1989","unstructured":"Renfro L, Grant-Kels J, Daman LA (1989) Drug-induced toxic epidermal necrolysis treated with cyclosporin. Int J Dermatol 28:441\u2013444","journal-title":"Int J Dermatol"},{"key":"607_CR22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","volume":"126","author":"JC Roujeau","year":"1990","unstructured":"Roujeau JC, Guillaume JC, Fabre JP, Penso D, Flechet ML, Girre JP (1990) Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981\u20131985. Arch Dermatol 126:37\u201342","journal-title":"Arch Dermatol"},{"key":"607_CR23","first-page":"873","volume":"38","author":"G Sanclemente","year":"1998","unstructured":"Sanclemente G, De la Roche C, Escobar C, Fabella R (1998) Pentoxifylline in toxic epidermal necrolysis and Stevens-Johnson syndrome. Int J Dermatol 38:873\u2013874","journal-title":"Int J Dermatol"},{"key":"607_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000051702","volume":"203","author":"M Stella","year":"2001","unstructured":"Stella M, Cassano P, Bollero D, Clemente A, Giorio G (2001) Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience. Dermatology 203:45\u201349","journal-title":"Dermatology"},{"key":"607_CR25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1440-0960.1996.tb01057.x","volume":"37","author":"JR Sullivan","year":"1996","unstructured":"Sullivan JR, Watson A (1996) Lamotrigine-induced toxic epidermal necrolysis treated with intravenous cyclosporin: a discussion of pathogenesis and immunosuppressive management. Australas J Dermatol 37:208\u2013212","journal-title":"Australas J Dermatol"},{"key":"607_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0926-9959(97)00047-0","volume":"9","author":"J Szepietowki","year":"1997","unstructured":"Szepietowki J, Wasik F, Szybejko-Machay G, May J (1997) Toxic epidermal necrolysis successfully treated with cyclosporin. Report of three cases. J Eur Acad Dermatol Venereol 9:169\u2013172","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"607_CR27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1067\/mai.2001.118796","volume":"108","author":"A Trautmann","year":"2001","unstructured":"Trautmann A, Akdis M, Schmid-Grendelmeier P, Disch R, Br\u00f6cker EB, Blaser K et al (2001) Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J Allergy Clin Immunol 108:839\u2013846","journal-title":"J Allergy Clin Immunol"},{"key":"607_CR28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.139.1.39","volume":"139","author":"JT Trent","year":"2003","unstructured":"Trent JT, Kirsner RS, Romanelli P, Kerdel FA (2003) Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN. Arch Dermatol 139:39\u201343","journal-title":"Arch Dermatol"},{"key":"607_CR29","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1067\/mjd.2002.127249","volume":"47","author":"P Tristani-Firouzi","year":"2002","unstructured":"Tristani-Firouzi P, Petersen M, Saffle JR, Morris SE, Zone JJ (2002) Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol 47:548\u2013552","journal-title":"J Am Acad Dermatol"},{"key":"607_CR30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D et al (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282:490\u2013493","journal-title":"Science"},{"key":"607_CR31","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","volume":"352","author":"P Wolkenstein","year":"1998","unstructured":"Wolkenstein P, Latarjet P, Roujeau JC (1998) Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 352:1586\u20131589","journal-title":"Lancet"},{"key":"607_CR32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.1995.tb02649.x","volume":"133","author":"I Zaki","year":"1995","unstructured":"Zaki I, Patel S, Reed R, Dalziel KL (1995) Toxic epidermal necrolysis associated with severe hypocalcaemia, and treated with cyclosporin. Br J Dermatol 133:337\u2013338","journal-title":"Br J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-005-0607-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-005-0607-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-005-0607-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T21:17:17Z","timestamp":1626643037000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-005-0607-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,26]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["607"],"URL":"https:\/\/doi.org\/10.1007\/s00403-005-0607-3","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,26]]}}}